PE20020792A1 - Antagonistas de receptores de aminoacidos excitadores - Google Patents
Antagonistas de receptores de aminoacidos excitadoresInfo
- Publication number
- PE20020792A1 PE20020792A1 PE2002000003A PE2002000003A PE20020792A1 PE 20020792 A1 PE20020792 A1 PE 20020792A1 PE 2002000003 A PE2002000003 A PE 2002000003A PE 2002000003 A PE2002000003 A PE 2002000003A PE 20020792 A1 PE20020792 A1 PE 20020792A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- refers
- acid
- antagonists
- amino acid
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title abstract 2
- 102000015404 Amino Acid Receptors Human genes 0.000 title 1
- 108010025177 Amino Acid Receptors Proteins 0.000 title 1
- -1 ISOQUINOLINE COMPOUND Chemical class 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N iso-quinoline Natural products C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 201000006474 Brain Ischemia Diseases 0.000 abstract 1
- 206010008120 Cerebral ischaemia Diseases 0.000 abstract 1
- 206010021143 Hypoxia Diseases 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 206010008118 cerebral infarction Diseases 0.000 abstract 1
- 230000007954 hypoxia Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 208000020431 spinal cord injury Diseases 0.000 abstract 1
- 238000001356 surgical procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26001401P | 2001-01-05 | 2001-01-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20020792A1 true PE20020792A1 (es) | 2002-09-06 |
Family
ID=22987455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2002000003A PE20020792A1 (es) | 2001-01-05 | 2002-01-04 | Antagonistas de receptores de aminoacidos excitadores |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1351955A1 (cs) |
| JP (1) | JP2004520335A (cs) |
| KR (1) | KR20030066797A (cs) |
| CN (1) | CN1484642A (cs) |
| AR (1) | AR035679A1 (cs) |
| BR (1) | BR0116672A (cs) |
| CA (1) | CA2431545A1 (cs) |
| CZ (1) | CZ20031856A3 (cs) |
| DZ (1) | DZ3460A1 (cs) |
| EA (1) | EA200300770A1 (cs) |
| EC (1) | ECSP034682A (cs) |
| HR (1) | HRP20030544A2 (cs) |
| HU (1) | HUP0302528A2 (cs) |
| IL (1) | IL156138A0 (cs) |
| MX (1) | MXPA03005981A (cs) |
| NO (1) | NO20032973D0 (cs) |
| NZ (1) | NZ525821A (cs) |
| PE (1) | PE20020792A1 (cs) |
| PL (1) | PL361934A1 (cs) |
| SK (1) | SK8242003A3 (cs) |
| TW (1) | TW591023B (cs) |
| WO (1) | WO2002053561A1 (cs) |
| ZA (1) | ZA200304311B (cs) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5284957A (en) * | 1992-09-03 | 1994-02-08 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| CA2319652A1 (en) * | 1998-02-06 | 1999-08-12 | Michael Urquhart | Salts of paroxetine |
| GB9908175D0 (en) * | 1999-04-09 | 1999-06-02 | Lilly Co Eli | Method of treating neurological disorders |
| EP1200073B1 (en) * | 1999-07-06 | 2007-01-10 | Eli Lilly And Company | SELECTIVE iGluR 5? RECEPTOR ANTAGONISTS FOR THE TREATMENT OF MIGRAINE |
-
2001
- 2001-12-20 JP JP2002554680A patent/JP2004520335A/ja active Pending
- 2001-12-20 EA EA200300770A patent/EA200300770A1/ru unknown
- 2001-12-20 CZ CZ20031856A patent/CZ20031856A3/cs unknown
- 2001-12-20 EP EP01995980A patent/EP1351955A1/en not_active Withdrawn
- 2001-12-20 HU HU0302528A patent/HUP0302528A2/hu unknown
- 2001-12-20 CN CNA018217508A patent/CN1484642A/zh active Pending
- 2001-12-20 WO PCT/US2001/044715 patent/WO2002053561A1/en not_active Ceased
- 2001-12-20 KR KR10-2003-7008977A patent/KR20030066797A/ko not_active Withdrawn
- 2001-12-20 PL PL01361934A patent/PL361934A1/xx not_active Application Discontinuation
- 2001-12-20 DZ DZ013460A patent/DZ3460A1/fr active
- 2001-12-20 SK SK824-2003A patent/SK8242003A3/sk unknown
- 2001-12-20 HR HR20030544A patent/HRP20030544A2/hr not_active Application Discontinuation
- 2001-12-20 MX MXPA03005981A patent/MXPA03005981A/es unknown
- 2001-12-20 IL IL15613801A patent/IL156138A0/xx unknown
- 2001-12-20 BR BR0116672-7A patent/BR0116672A/pt not_active IP Right Cessation
- 2001-12-20 CA CA002431545A patent/CA2431545A1/en not_active Abandoned
- 2001-12-20 NZ NZ525821A patent/NZ525821A/en unknown
-
2002
- 2002-01-04 TW TW091100071A patent/TW591023B/zh not_active IP Right Cessation
- 2002-01-04 PE PE2002000003A patent/PE20020792A1/es not_active Application Discontinuation
- 2002-01-04 AR ARP020100030A patent/AR035679A1/es not_active Application Discontinuation
-
2003
- 2003-06-02 ZA ZA200304311A patent/ZA200304311B/en unknown
- 2003-06-27 NO NO20032973A patent/NO20032973D0/no not_active Application Discontinuation
- 2003-07-03 EC EC2003004682A patent/ECSP034682A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DZ3460A1 (fr) | 2002-07-11 |
| MXPA03005981A (es) | 2003-09-10 |
| NZ525821A (en) | 2004-07-30 |
| BR0116672A (pt) | 2003-09-23 |
| TW591023B (en) | 2004-06-11 |
| SK8242003A3 (en) | 2004-01-08 |
| ZA200304311B (en) | 2004-09-02 |
| CA2431545A1 (en) | 2002-07-11 |
| NO20032973L (no) | 2003-06-27 |
| NO20032973D0 (no) | 2003-06-27 |
| KR20030066797A (ko) | 2003-08-09 |
| IL156138A0 (en) | 2003-12-23 |
| CZ20031856A3 (cs) | 2003-09-17 |
| EP1351955A1 (en) | 2003-10-15 |
| WO2002053561A1 (en) | 2002-07-11 |
| JP2004520335A (ja) | 2004-07-08 |
| HUP0302528A2 (hu) | 2003-11-28 |
| CN1484642A (zh) | 2004-03-24 |
| EA200300770A1 (ru) | 2003-10-30 |
| PL361934A1 (en) | 2004-10-18 |
| AR035679A1 (es) | 2004-06-23 |
| HRP20030544A2 (en) | 2004-08-31 |
| ECSP034682A (es) | 2003-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2018386298B2 (en) | Inhibitors of fibroblast activation protein | |
| AU754716B2 (en) | Amide derivatives and nociceptin antagonists | |
| PE20230249A1 (es) | Compuestos de heteroarilo biciclicos y usos de estos | |
| ES2702474T3 (es) | Ciclohexilmetanosulfonamidas | |
| PE20120418A1 (es) | DERIVADOS DE PIRIDO[2,3-b]PIRAZINA COMO INHIBIDORES DE POLI (ADP-RIBOSA) POLIMERASA (PARP) | |
| KR20050122210A (ko) | 히스톤 탈아세틸화 효소 억제제 | |
| EP2138489B1 (en) | Novel pyrimidine compound having benzyl(heterocyclicmethyl)amine structure and pharmaceutical product containing the same | |
| AR036103A1 (es) | Imidazotriazinas, procedimiento para su preparacion, uso de dichos compuestos para la manufactura de un medicamento para enfermedades neurodegenerativas y dicho medicamento | |
| PE20060570A1 (es) | Compuestos de quinazolina e isoquinolina piperidilo sustituidos como inhibidores de fosfodiesterasa pde-10 | |
| PE20020721A1 (es) | Derivados de quinuclidina como agentes antimuscarinicos m3 | |
| PL1716152T3 (pl) | Skondensowane związki heterocykliczne i ich zastosowanie jako antagonistów receptora metabotropowego do leczenia zaburzeń żołądkowo-jelitowych | |
| NO20062139L (no) | Dihydrobenzofuranyl-alkanaminderivater som 5HT2C-agonister | |
| ES2966369T3 (es) | Compuestos y métodos para el tratamiento de enfermedades parasitarias | |
| ECSP088293A (es) | Inhibidores de gamma secretasa, de sulfonamido n-cíclico puenteado | |
| CN111566095A (zh) | 被取代的吡咯并吡啶jak抑制剂及其制造方法和使用方法 | |
| TW200519096A (en) | Quinazoline analogs as receptor tyrosine kinase inhibitors | |
| AR053566A1 (es) | Compuestos espiriciclicos antagonistas de los receptores de trombina | |
| TWI662019B (zh) | Fused tricyclic γ-amino acid derivative, preparation method and application thereof in medicine | |
| BRPI0408988A (pt) | composto de piperidinilamino-tieno[2,3-d]pirimidina | |
| ATE399770T1 (de) | Tachykininrezeptorantagonisten | |
| NO985518L (no) | Morfinanderivater og medisinsk anvendelse derav | |
| EA200200952A1 (ru) | Производные циклогексиламина в качестве селективных антагонистов подтипов nmda-рецепторов | |
| BR0206495A (pt) | Tratamento de distúrbios de cns empregando antagonistas de oxidase de d-aminoácido e oxidase de d-aspartato | |
| PE20080176A1 (es) | Compuestos de arilpiperazina sulfonamida como agonista de los receptores de secretagogos de la hormona de crecimiento (ghs) | |
| GT200000197A (es) | 2-(3,5-bis-trifluorometil-fenil)-n-metil-n-(6- morfolin-4-il-4-o tolil-piridin-3-il)-isobutiramida. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |